Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate Other stock markets 09:40:05 2026-07-28 am EDT			5-day change	1st Jan Change
59.52 ^EUR	+0.46%		+8.32%	-6.69%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Fundamentals
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.45B	BBB
ELI LILLY AND COMPANY	1,068B	A
JOHNSON & JOHNSON	641B	BBB
ABBVIE INC.	454B	AA	-
ROCHE HOLDING AG	351B	AA
NOVARTIS AG	299B	AAA
ASTRAZENECA PLC	266B	A
NOVO NORDISK A/S	220B	A
AMGEN INC.	203B	A
GILEAD SCIENCES, INC.	162B	AA
PFIZER INC.	141B	A
BRISTOL-MYERS SQUIBB COMPANY	128B	A
VERTEX PHARMACEUTICALS INCORPORATED	122B	AA
SANOFI	106B	AA
GSK PLC	104B	AA
CHUGAI PHARMACEUTICAL CO., LTD.	68.84B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.28B	AA
BAYER AG	52.78B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.23B	AA
HALEON PLC	43.39B	AA
Average	227.03B	AA
Weighted average by Cap.		AA